Cargando…

Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats

Background Recently, we showed that long-term angiotensin receptor blocker (ARB) administration induced unusual proliferative changes in smooth muscle cells (SMCs) of afferent arterioles of the kidneys of Zucker fatty rats (ZFRs). In this study, we investigated renal afferent arteriolar changes indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakanishi, Kazushige, Nagai, Yohko, Akimoto, Tatsuo, Yamanaka, Nobuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Society of Smooth Muscle Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364377/
https://www.ncbi.nlm.nih.gov/pubmed/28260705
http://dx.doi.org/10.1540/jsmr.53.20
_version_ 1782517305008193536
author Nakanishi, Kazushige
Nagai, Yohko
Akimoto, Tatsuo
Yamanaka, Nobuaki
author_facet Nakanishi, Kazushige
Nagai, Yohko
Akimoto, Tatsuo
Yamanaka, Nobuaki
author_sort Nakanishi, Kazushige
collection PubMed
description Background Recently, we showed that long-term angiotensin receptor blocker (ARB) administration induced unusual proliferative changes in smooth muscle cells (SMCs) of afferent arterioles of the kidneys of Zucker fatty rats (ZFRs). In this study, we investigated renal afferent arteriolar changes induced by the long-term administration of an angiotensin converting enzyme inhibitor (ACEI) in ZFRs. Materials and Methods Fourteen 6-week-old male ZFRs were divided into two groups (n=14): the ZFR+ACEI group (n=6) was fed a standard diet containing ACEI (Enalapril, 2 mg/kg/day), and the ZFR control group (n=8) for 12 weeks. Blood pressure and proteinuria were examined and morphological studies on kidneys were performed. Results Remarkable proliferative changes in the afferent arteriolar SMCs were frequently observed in the group given ACEI; (66.1 ± 12.9%) compared with the control group (1.77 ± 1.56%, P<0.001). Conclusions It was indicated that long-term ACEI administration induced unusual proliferative changes in SMCs in afferent arterioles of ZFRs. These changes could reduce intraglomerular pressure by narrowing the lumens of afferent arterioles, but they could cause irreversible damage to the arterioles.
format Online
Article
Text
id pubmed-5364377
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Japan Society of Smooth Muscle Research
record_format MEDLINE/PubMed
spelling pubmed-53643772017-03-24 Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats Nakanishi, Kazushige Nagai, Yohko Akimoto, Tatsuo Yamanaka, Nobuaki J Smooth Muscle Res Original Background Recently, we showed that long-term angiotensin receptor blocker (ARB) administration induced unusual proliferative changes in smooth muscle cells (SMCs) of afferent arterioles of the kidneys of Zucker fatty rats (ZFRs). In this study, we investigated renal afferent arteriolar changes induced by the long-term administration of an angiotensin converting enzyme inhibitor (ACEI) in ZFRs. Materials and Methods Fourteen 6-week-old male ZFRs were divided into two groups (n=14): the ZFR+ACEI group (n=6) was fed a standard diet containing ACEI (Enalapril, 2 mg/kg/day), and the ZFR control group (n=8) for 12 weeks. Blood pressure and proteinuria were examined and morphological studies on kidneys were performed. Results Remarkable proliferative changes in the afferent arteriolar SMCs were frequently observed in the group given ACEI; (66.1 ± 12.9%) compared with the control group (1.77 ± 1.56%, P<0.001). Conclusions It was indicated that long-term ACEI administration induced unusual proliferative changes in SMCs in afferent arterioles of ZFRs. These changes could reduce intraglomerular pressure by narrowing the lumens of afferent arterioles, but they could cause irreversible damage to the arterioles. Japan Society of Smooth Muscle Research 2017-03-03 2017 /pmc/articles/PMC5364377/ /pubmed/28260705 http://dx.doi.org/10.1540/jsmr.53.20 Text en ©2017 The Japan Society of Smooth Muscle Research This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original
Nakanishi, Kazushige
Nagai, Yohko
Akimoto, Tatsuo
Yamanaka, Nobuaki
Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats
title Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats
title_full Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats
title_fullStr Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats
title_full_unstemmed Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats
title_short Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats
title_sort changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in zucker fatty rats
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364377/
https://www.ncbi.nlm.nih.gov/pubmed/28260705
http://dx.doi.org/10.1540/jsmr.53.20
work_keys_str_mv AT nakanishikazushige changesinrenalvesselsassociatedwithlongtermadministrationofangiotensinconvertingenzymeinhibitorinzuckerfattyrats
AT nagaiyohko changesinrenalvesselsassociatedwithlongtermadministrationofangiotensinconvertingenzymeinhibitorinzuckerfattyrats
AT akimototatsuo changesinrenalvesselsassociatedwithlongtermadministrationofangiotensinconvertingenzymeinhibitorinzuckerfattyrats
AT yamanakanobuaki changesinrenalvesselsassociatedwithlongtermadministrationofangiotensinconvertingenzymeinhibitorinzuckerfattyrats